Summary of pregnancy outcomes in the safety population.

NIAID Data Ecosystem2026-03-09 收录

药物妊娠安全性

临床试验生殖结局

数据链接：

https://figshare.com/articles/dataset/Summary_of_pregnancy_outcomes_in_the_safety_population_/4243469 数据链接链接失效反馈

官方服务：

资源简介：

Summary of pregnancy outcomes in the safety population.

创建时间：

2016-11-19

Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study

药物妊娠安全性

自身免疫性疾病妊娠结局

Background Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. Methods and findings Between 2004 and 2016, the Organization of Te

NIAID Data Ecosystem90

Table 2 -

药物妊娠安全性

围产期健康结局

A. Association between study medication exposures during pregnancy and the risk of prematurity. B. Association between study medication exposures during pregnancy and the risk of low birth weight (LBW

NIAID Data Ecosystem50

Birth prevalence of major structural birth defects in pregnancies exposed to adalimumab compared to unexposed pregnancies, 2004–2016.

药物妊娠安全性

出生缺陷流行病学

Birth prevalence of major structural birth defects in pregnancies exposed to adalimumab compared to unexposed pregnancies, 2004–2016.

NIAID Data Ecosystem40

Supplementary Tables – Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting System

药物妊娠安全性

药物不良事件

List of antineoplastic agents included in the current analysis

Figshare2022-05-25 更新50

Table_1_Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis.docx

药物妊娠安全性

围产期结局

Interferon (IFN) treatment is widely applied in viral hepatitis and multiple myeloproliferative diseases. However, there is considerable controversy on how to deal with unintended pregnancy during IFN

NIAID Data Ecosystem40

Summary of pregnancy outcomes in the safety population.

资源简介：

相关数据集